Tag: PREIND
ABIONYX Pharma successfully passed the pre-IND meeting with the FDA for a phase 2b/3 clinical study evaluating CER-001 in the treatment of patients with sepsis – 06/13/2024 at 7:30 p.m.
• Based on promising data from its Phase 2a study and a successful meeting with the Food and Drug Administration (FDA), ABIONYX Pharma will file an IND application in the…
NFL BIOSCIENCES: FILING OF A PRE-IND APPLICATION WITH THE FDA IN THE UNITED STATES FOR NFL-301 DEDICATED TO THE REDUCTION OF ALCOHOL CONSUMPTION – 12/19/2023 at 08:00
NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs for the treatment of dependencies and addictions, announces that it has today filed a pre-IND…